Christopher Szot

1.9k total citations
16 papers, 900 citations indexed

About

Christopher Szot is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Christopher Szot has authored 16 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Biomedical Engineering and 7 papers in Oncology. Recurrent topics in Christopher Szot's work include 3D Printing in Biomedical Research (6 papers), Cancer Cells and Metastasis (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Christopher Szot is often cited by papers focused on 3D Printing in Biomedical Research (6 papers), Cancer Cells and Metastasis (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Christopher Szot collaborates with scholars based in United States, Netherlands and Sweden. Christopher Szot's co-authors include Marissa Nichole Rylander, Cara F. Buchanan, Joseph W. Freeman, Christopher B. Arena, Rafael V. Davalos, Suzy V. Torti, Heather Hatcher, Saugata Sarkar, Christopher G. Rylander and Jon Whitney and has published in prestigious journals such as PLoS ONE, Biomaterials and Cancer Research.

In The Last Decade

Christopher Szot

16 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Szot United States 9 653 210 193 180 178 16 900
Laure Gibot France 19 676 1.0× 153 0.7× 260 1.3× 383 2.1× 376 2.1× 53 1.4k
Cara F. Buchanan United States 12 921 1.4× 286 1.4× 32 0.2× 264 1.5× 280 1.6× 16 1.2k
Junfeng Shi United States 14 469 0.7× 75 0.4× 186 1.0× 420 2.3× 97 0.5× 19 937
Alexander E. G. Baker Canada 15 395 0.6× 75 0.4× 27 0.1× 199 1.1× 261 1.5× 22 935
Jieun Han South Korea 20 654 1.0× 124 0.6× 62 0.3× 408 2.3× 197 1.1× 37 1.2k
Maxence O. Dellacherie United States 12 513 0.8× 340 1.6× 53 0.3× 426 2.4× 150 0.8× 13 1.1k
Sabina Pozzi Israel 13 501 0.8× 319 1.5× 32 0.2× 367 2.0× 196 1.1× 24 1.1k
Wenfei Chen China 17 800 1.2× 112 0.5× 348 1.8× 418 2.3× 280 1.6× 39 1.5k
Ana Sofia Ribeiro Portugal 22 211 0.3× 460 2.2× 82 0.4× 732 4.1× 215 1.2× 59 1.4k
David Zhang United States 17 449 0.7× 431 2.1× 38 0.2× 484 2.7× 156 0.9× 25 1.3k

Countries citing papers authored by Christopher Szot

Since Specialization
Citations

This map shows the geographic impact of Christopher Szot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Szot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Szot more than expected).

Fields of papers citing papers by Christopher Szot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Szot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Szot. The network helps show where Christopher Szot may publish in the future.

Co-authorship network of co-authors of Christopher Szot

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Szot. A scholar is included among the top collaborators of Christopher Szot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Szot. Christopher Szot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sill, Michael W., Bradley J. Monk, Michael J. Birrer, et al.. (2023). PIK3CA and ARID1A mutations in recurrent/metastatic cervical cancer: The NRG Oncology/Gynecologic Oncology Group-0240 National Institutes of Health Beau Biden Cancer Moonshot (LBA 2). Gynecologic Oncology. 176. S28–S29. 1 indexed citations
2.
Boguslawski, Elissa A., et al.. (2016). Anthrax Toxin Receptor 1 Is Essential for Arteriogenesis in a Mouse Model of Hindlimb Ischemia. PLoS ONE. 11(1). e0146586–e0146586. 2 indexed citations
3.
Byrd, Tiara T., Kristen Fousek, Antonella Pignata, et al.. (2016). Abstract 2312: TEM8/ANTXR1 specific T cells co-target tumor stem cells and tumor vasculature in triple-negative breast cancer. Cancer Research. 76(14_Supplement). 2312–2312. 3 indexed citations
4.
Sano, Michael B., Christopher B. Arena, Matthew R. DeWitt, et al.. (2015). Bursts of Bipolar Microsecond Pulses Inhibit Tumor Growth. Scientific Reports. 5(1). 14999–14999. 102 indexed citations
5.
Byrd, Tiara T., Kristen Fousek, Antonella Pignata, et al.. (2015). 720. Triple-Negative Breast Cancer Cells and Tumor Endothelium Are Killed by Targeting Tumor Endothelial Marker 8 (TEM8). Molecular Therapy. 23. S287–S288. 1 indexed citations
6.
Kuo, Frank C., Stephanie Histed, Biying Xu, et al.. (2014). Immuno-PET Imaging of Tumor Endothelial Marker 8 (TEM8). Molecular Pharmaceutics. 11(11). 3996–4006. 17 indexed citations
7.
Szot, Christopher, Cara F. Buchanan, Joseph W. Freeman, & Marissa Nichole Rylander. (2013). In Vitro Angiogenesis Induced by Tumor-Endothelial Cell Co-Culture in Bilayered, Collagen I Hydrogel Bioengineered Tumors. Tissue Engineering Part C Methods. 19(11). 864–874. 49 indexed citations
8.
Buchanan, Cara F., et al.. (2013). Three-Dimensional Microfluidic Collagen Hydrogels for Investigating Flow-Mediated Tumor-Endothelial Signaling and Vascular Organization. Tissue Engineering Part C Methods. 20(1). 64–75. 109 indexed citations
9.
Arena, Christopher B., Christopher Szot, Paulo A. Garcia, Marissa Nichole Rylander, & Rafael V. Davalos. (2012). A Three-Dimensional In Vitro Tumor Platform for Modeling Therapeutic Irreversible Electroporation. Biophysical Journal. 103(9). 2033–2042. 81 indexed citations
10.
Buchanan, Cara F., Christopher Szot, Steven A. Akman, et al.. (2011). Cross‐talk between endothelial and breast cancer cells regulates reciprocal expression of angiogenic factors in vitro. Journal of Cellular Biochemistry. 113(4). 1142–1151. 41 indexed citations
11.
Szot, Christopher, Christopher B. Arena, Paulo A. Garcia, et al.. (2011). A Novel In Vitro Model for Irreversible Electroporation Based Cancer Therapies and Treatment Planning. 485–486. 1 indexed citations
12.
Szot, Christopher, Cara F. Buchanan, Joseph W. Freeman, & Marissa Nichole Rylander. (2011). 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials. 32(31). 7905–7912. 237 indexed citations
13.
Szot, Christopher, Cara F. Buchanan, Marissa Nichole Rylander, & Joseph W. Freeman. (2011). Cancer cells cultured within collagen I hydrogels exhibit an in vivo solid tumor phenotype. 1–2. 2 indexed citations
14.
Buchanan, Cara F., Christopher Szot, Joseph W. Freeman, & M. Nichole Rylander. (2011). 2D and 3D in vitro culture methods to investigate endothelial-cell enhanced tumor angiogenesis. 1–2. 3 indexed citations
15.
Sarkar, Saugata, Cara F. Buchanan, Christopher Szot, et al.. (2010). Photothermal Response of Human and Murine Cancer Cells to Multiwalled Carbon Nanotubes after Laser Irradiation. Cancer Research. 70(23). 9855–9864. 209 indexed citations
16.
Szot, Christopher, Cara F. Buchanan, Paul Gatenholm, Marissa Nichole Rylander, & Joseph W. Freeman. (2009). Investigation of cancer cell behavior on nanofibrous scaffolds. Materials Science and Engineering C. 31(1). 37–42. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026